Literature DB >> 33396401

Micro- to Nanoscale Bio-Hybrid Hydrogels Engineered by Ionizing Radiation.

Clelia Dispenza1,2, Daniela Giacomazza2, Mats Jonsson3.   

Abstract

Bio-hybrid hydrogels consist of a water-swollen hydrophilic polymer network encapsulating or conjugating single biomolecules, or larger and more complex biological constructs like whole cells. By modulating at least one dimension of the hydrogel system at the micro- or nanoscale, the activity of the biological component can be extremely upgraded with clear advantages for the development of therapeutic or diagnostic micro- and nano-devices. Gamma or e-beam irradiation of polymers allow a good control of the chemistry at the micro-/nanoscale with minimal recourse to toxic reactants and solvents. Another potential advantage is to obtain simultaneous sterilization when the absorbed doses are within the sterilization dose range. This short review will highlight opportunities and challenges of the radiation technologies to produce bio-hybrid nanogels as delivery devices of therapeutic biomolecules to the target cells, tissues, and organs, and to create hydrogel patterns at the nano-length and micro-length scales on surfaces.

Entities:  

Keywords:  bio-hybrid hydrogels; drug delivery; micro-/nano-gel patterns; nanogels; radiation chemistry; tissue engineering

Mesh:

Substances:

Year:  2020        PMID: 33396401      PMCID: PMC7824687          DOI: 10.3390/biom11010047

Source DB:  PubMed          Journal:  Biomolecules        ISSN: 2218-273X


  54 in total

1.  Polycaprolactone nanofiber mats decorated with photoresponsive nanogels and silver nanoparticles: Slow release for antibacterial control.

Authors:  Camilo A S Ballesteros; Daniel S Correa; Valtencir Zucolotto
Journal:  Mater Sci Eng C Mater Biol Appl       Date:  2019-10-19       Impact factor: 7.328

2.  Morphing hydrogel patterns by thermo-reversible fluorescence switching.

Authors:  Erhan Bat; En-Wei Lin; Sina Saxer; Heather D Maynard
Journal:  Macromol Rapid Commun       Date:  2014-04-17       Impact factor: 5.734

Review 3.  "Nanogels as drug carriers - Introduction, chemical aspects, release mechanisms and potential applications".

Authors:  Saurabh Shah; Nagarjun Rangaraj; Kritika Laxmikeshav; Sunitha Sampathi
Journal:  Int J Pharm       Date:  2020-03-30       Impact factor: 5.875

4.  Designing nanogel carriers for antibacterial applications.

Authors:  M Carme Coll Ferrer; Sana Dastgheyb; Noreen J Hickok; David M Eckmann; Russell J Composto
Journal:  Acta Biomater       Date:  2014-01-13       Impact factor: 8.947

Review 5.  Advancement in the Biomedical Applications of the (Nano)gel Structures Based on Particular Polysaccharides.

Authors:  Aurica P Chiriac; Alina Ghilan; Iordana Neamtu; Loredana E Nita; Alina G Rusu; Vlad Mihai Chiriac
Journal:  Macromol Biosci       Date:  2019-08-02       Impact factor: 4.979

Review 6.  Passive and Active Drug Targeting: Role of Nanocarriers in Rational Design of Anticancer Formulations.

Authors:  Ram P Das; Vishwa V Gandhi; Beena G Singh; Amit Kunwar
Journal:  Curr Pharm Des       Date:  2019       Impact factor: 3.116

7.  Spatially controlled bacterial adhesion using surface-patterned poly(ethylene glycol) hydrogels.

Authors:  Peter Krsko; Jeffrey B Kaplan; Matthew Libera
Journal:  Acta Biomater       Date:  2008-09-21       Impact factor: 8.947

8.  Nose-to-brain delivery of insulin enhanced by a nanogel carrier.

Authors:  Pasquale Picone; Maria Antonietta Sabatino; Lorena Anna Ditta; Antonella Amato; Pier Luigi San Biagio; Flavia Mulè; Daniela Giacomazza; Clelia Dispenza; Marta Di Carlo
Journal:  J Control Release       Date:  2017-12-02       Impact factor: 9.776

9.  Basic concepts and recent advances in nanogels as carriers for medical applications.

Authors:  Iordana Neamtu; Alina Gabriela Rusu; Alina Diaconu; Loredana Elena Nita; Aurica P Chiriac
Journal:  Drug Deliv       Date:  2017-11       Impact factor: 6.419

10.  Global, regional, and national burden of brain and other CNS cancer, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016.

Authors: 
Journal:  Lancet Neurol       Date:  2019-02-21       Impact factor: 44.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.